Researchers
Stepanović, Ana
Results 1-20 of 40
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures | Podolski-Renić, Ana   ; Jovanović Stojanov, Sofija ; Marić, Dragana ; Dinić, Jelena ; Dragoj, Miodrag ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Glumac, Sofija; Ercegovac, Maja;
Pešić, Milica
; | Article | 22M22 |
| 2025 | Impact of ex vivo cell culturing on ABC transporters' expression and drug sensitivity in patient-derived non-small cell lung cancer models | Dinic, Jelena B ; Jovanovic-Stojanov, Sofija M ; Lupsic, Ema ; Pajovic, Milica ; Stepanovic, Ana ; Dragoj, Miodrag ; Podolski-Renic, Ana M ; Pesic, Milica S | Article | 22M22 |
| 2025 | Personalized Genomic Analysis for Clinical Insights in Non-Small Cell Lung Cancer | Dragoj, Miodrag ; Jovanović Stojanov, Sofija ; Podolski-Renić, Ana ; Dinić, Jelena ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Petrović Rodić, Dušica; Glumac, Sofija; Marić, Dragana;
Ercegovac, Maja; Pešić, Milica
; | Conference Paper | Mp. category will be shown later |
| 2025 | Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells | Stojković, Pavle ; Lupšić, Ema ; Terzić-Jovanović, Nataša ; Stepanović, Ana ; Nedialkov, Paraskev; Podolski-Renić, Ana M. ; Pešić, Milica ; Opsenica, Igor M. | Article | 21aM21a |
| 2024 | Advancements in Personalized Therapy for Non-Small Cell Lung Carcinoma: The Role of Functional Diagnostics | Dinić, Jelena ; Dragoj, Miodrag ; Jovanović Stojanov, Sofija ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Glumac, Sofija; Marić, Dragana ; Ercegovac, Maja; Podolski-Renić, Ana ;
Pešić, Milica
; | Conference Paper | Mp. category will be shown later |
| 2024 | Synthesis and anticancer activity of novel sclareol derivatives | Ajdačić, Vladimir; Stojković, Pavle; Nikolić, Andrea; Andrijević, Ana; Lupšić, Ema ; Stepanović, Ana ; Podolski-Renić, Ana ; Terzić-Jovanović, Nataša; Pešić, Milica ; Opsenica, Igor M. | Conference Paper | Mp. category will be shown later |
| 2024 | Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma | Stepanović, Ana ; Terzić Jovanović, Nataša ; Korać, Aleksandra ; Zlatović, Mario ; Nikolić, Igor ; Opsenica, Igor ; Pešić, Milica | Article | 21a+M21a+ |
| 2024 | Functional Diagnostics in Personalized Therapy for Non-Small Cell Lung Carcinoma | Podolski-Renić, Ana ; Dinić, Jelena ; Dragoj, Miodrag ; Jovanović Stojanov, Sofija ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Glumac, Sofija; Marić, Dragana ; Ercegovac, Maja;
Pešić, Milica
; | Conference Paper | Mp. category will be shown later |
| 2024 | Hybrid Compounds of Sclareol and Doxorubicin, their Synthesis and Application | Pešić, Milica ; Opsenica, Igor; Stepanović, Ana ; Terzić-Jovanović, Nataša | Patent | Mp. category will be shown later |
| 2024 | Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors | Dinić, Jelena ; Dragoj, Miodrag ; Jovanović Stojanov, Sofija ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Mohr, Thomas; Glumac, Sofija; Marić, Dragana ; Ercegovac, Maja;
Podolski-Renić, Ana
; Pešić, Milica ; | Article | 21M21 |
| 2024 | Integrating functional screening and bioinformatics for personalized medicine approaches in NSCLC | Dragoj, Miodrag ; Dinić, Jelena ; Jovanović Stojanov, Sofija ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Mohr, Thomas; Glumac, Sofija; Marić, Dragana ; Ercegovac, Maja;
Podolski-Renić, Ana
; Pešić, Milica ; | Conference Paper | Mp. category will be shown later |
| 2024 | Functional diagnostics in non-small cell lung carcinoma - the potential for personalized approach | Lupšić, Ema ; Dinić, Jelena ; Dragoj, Miodrag ; Jovanović Stojanov, Sofija ; Stepanović, Ana ; Pajović, Milica ; Mohr, Thomas; Glumac, Sofija; Marić, Dragana ; Ercegovac, Maja;
Podolski-Renić, Ana
; Pešić, Milica ; | Conference Paper | Mp. category will be shown later |
| 2023 | Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts | Jovanović Stojanov, Sofija ; Podolski-Renić, Ana ; Dinić, Jelena ; Dragoj, Miodrag ; Jovanović, Mirna ; Stepanović, Ana ; Lupšić, Ema ; Bajović, Radovan; Glumac, Sofija ; Marić, Dragana ;
Ercegovac, Maja
; Pešić, Milica ; | Conference Paper | Mp. category will be shown later |
| 2023 | High-throughput screening of multidrug-resistance markers in non-small cell lung carcinoma patient-derived cells - contribution to personalized treatment | Jovanović Stojanov, Sofija ; Podolski-Renić, Ana ; Dinić, Jelena ; Dragoj, Miodrag ; Jovanović, Mirna ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Petrović Rodić, Dušica; Marić, Dragana ;
Ercegovac, Maja; Pešić, Milica
; | Conference Paper | Mp. category will be shown later |
| 2023 | Novel functional immunoassay for identification of multidrug resistance markers in non-small cell lung carcinoma patient-derived cells | Stepanović, Ana ; Dinić, Jelena ; Podolski-Renić, Ana ; Jovanović-Stojanov, Sofija ; Dragoj, Miodrag ; Jovanović, Mirna ; Lupšić, Ema ; Milićević, Aleksandar; Glumac, Sofija ; Marić, Dragana ;
Ercegovac, Maja
; Pešić, Milica ; | Conference Paper | Mp. category will be shown later |
| 2023 | Sinteza i citotoksičnost novih derivata sklareola | Stojković, Pavle A.; Kostić, Ana ; Lupšić, Ema ; Terzić Jovanović, Nataša; Novaković, Miroslav; Pešić, Milica ; Opsenica, Igor M. | Conference Paper | Mp. category will be shown later |
| 2023 | New anti-glioblastoma strategy with natural compounds sclareol and doxorubicin | Stepanović, Ana ; Lupšić, Ema ; Dinić, Jelena ; Podolski-Renić, Ana ; Pajović, Milica ; Jovanović Stojanov, Sofija ; Dragoj, Miodrag ; Terzić Jovanović, Nataša ; Opsenica, Igor ; Pešić, Milica | Conference Paper | Mp. category will be shown later |
| 2023 | Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells | Dinić, Jelena ; Podolski-Renić, Ana ; Dragoj, Miodrag ; Jovanović Stojanov, Sofija ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Jovanović, Mirna ; Petrović Rodić, Dušica; Marić, Dragana ;
Ercegovac, Maja; Pešić, Milica
; | Article | 21M21 |
| 2023 | Evading multidrug resistance in glioblastoma with natural compound sclareol and its novel derivatives | Lupšić, Ema ; Stepanović, Ana ; Stojković, Pavle; Terzić-Jpvanović, Nataša; Novaković, Miroslav; Nedialkov, Paraskev; Trendafilova, Antoaneta; Opsenica, Igor M.; Pešić, Milica | Conference Paper | Mp. category will be shown later |
| 2023 | Functional diagnostics and ex-vivo screening of erlotinib and nintedanib in non-small cell lung carcinoma: Implications for multidrug resistance and personalized therapy | Dinić, Jelena ; Podolski-Renić, Ana ; Dragoj, Miodrag ; Jovanović Stojanov, Sofija ; Stepanović, Ana ; Lupšić, Ema ; Pajović, Milica ; Petrović Rodić, Dušica; Marić, Dragana ; Ercegovac, Maja;
Pešić, Milica
; | Conference Paper | Mp. category will be shown later |